Day: June 24, 2021

Artesian Wastewater Management, Inc. Commences Operation of Its Sussex Regional Water Recharge Facility

Artesian Wastewater Management, Inc. Commences Operation of Its Sussex Regional Water Recharge Facility

NEWARK, Del., June 24, 2021 (GLOBE NEWSWIRE) — Artesian Wastewater Management, Inc. (Artesian) began accepting treated effluent from Allen Harim today, commencing full operation of Artesian’s Sussex Regional Recharge Facility (SRRF). Over the past four years, Artesian made extensive and beneficial investments in its regional facility while also providing services and resources to Allen Harim in order to successfully complete this important project. Completion of the project allows Allen Harim to meet its regulatory permit requirement to cease wastewater discharge to the Beaverdam Creek at its Harbeson, Delaware plant. Artesian’s 90 million gallon storage lagoon and nearly 9 miles of treated effluent force mains are the culmination of years-long efforts to provide proper wastewater solutions for Allen Harim’s Harbeson facility,...

Continue reading

Synchronoss Technologies, Inc. Announces Proposed $100 Million Public Offering of Common Stock

Synchronoss Technologies, Inc. Announces Proposed $100 Million Public Offering of Common Stock

BRIDGEWATER, N.J., June 24, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (SNCR) (the “Company” or “Synchronoss”), a global leader and innovator in cloud, messaging and digital products and platforms, today announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering. Synchronoss also expects to grant the underwriters a 30-day option to purchase up to an additional $10 million of shares of common stock sold in the offering, at the public offering price, less the underwriting discounts and commissions. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares in the offering are to be sold by Synchronoss, with net proceeds...

Continue reading

BankFinancial Corporation Expands Share Repurchase Program

BankFinancial Corporation Expands Share Repurchase Program

BURR RIDGE, Ill., June 24, 2021 (GLOBE NEWSWIRE) — The Board of Directors of BankFinancial Corporation (the “Company”) increased the total number of shares currently authorized for repurchase under the Share Repurchase Program by 900,000 shares. As of June 24, 2021, a total of 99,661 shares remained authorized for purchase pursuant to the previous share repurchase authorization. Therefore, as of June 24, 2021, the total number of shares authorized for repurchase is 999,661. The share repurchase authorization remains in effect through November 15, 2021. The authorization permits shares to be repurchased in open market or negotiated transactions, and pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities and Exchange Commission. The authorization will be utilized at management’s...

Continue reading

Adial Pharmaceuticals Provides Regulatory and Development Update

Adial Pharmaceuticals Provides Regulatory and Development Update

CHARLOTTESVILLE, Va., June 24, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it has received correspondence related to its request for Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its drug candidate, AD04, for the treatment of Alcohol Use Disorder (AUD) in pediatric patients and adult patients with Alcoholic Liver Disease (ALD) with select polymorphisms of the serotonin transporter and receptor genes. While AD04 is being developed and undergoing a pivotal Phase 3 trial to treat any adult with AUD with the targeted genetics, Adial believes AD04 holds the potential to effectively and safely treat AUD patients that are adolescents or have ALD. The Company...

Continue reading

DIRTT Expands Litigation Against Falkbuilt in Texas and Seeks Order Compelling Smed and Loberg to Attend Depositions in Canada

DIRTT Expands Litigation Against Falkbuilt in Texas and Seeks Order Compelling Smed and Loberg to Attend Depositions in Canada

CALGARY, Alberta, June 24, 2021 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT”) (TSX: DRT, NASDAQ: DRTT) an interior construction company that uses proprietary software to design, manufacture and install fully customizable environments, announces that it has expanded its litigation against Falkbuilt (a company started by two of DIRTT’s founders Mogens Smed and Barrie Loberg), and continues to aggressively pursue Smed, Loberg and Falkbuilt via four separate lawsuits across North America, as outlined below. Kevin O’Meara, chief executive officer, stated, “Our primary focus is the successful execution of our strategic plan and capturing the benefits of improving construction market conditions, however we also remain steadfast in our commitment to vigorously defend the value of our business, our brand and the interests...

Continue reading

Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results

Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results

Field Trip completes FY2021 as the largest vertically integrated psychedelics company positioned to be a leader in the emerging industry Continues to leverage its early mover opportunity by investing in its drug development strategy and the build out of a globally recognized brand of psychedelic-assisted therapy centers Closed FY2021 with $111,817,443 in unrestricted cash and cash equivalents, funds held in trust and short-term investments after successfully completing two bought deal offerings for gross proceeds of $115 million Development of FT-104, a novel psychedelic molecule with pending patents, continues to progress with GMP production underway in preparation for Phase 1 studies 6 Field Trip Health centers have commenced operations and are in early stages of ramp up to break-even; Q4 2021 patient services revenues grew by 66%...

Continue reading

Mainframe Expands into 2D Series Production

Mainframe Expands into 2D Series Production

WOW!’s Mainframe Studios Diversifies Storytelling Capabilities VANCOUVER, Canada, June 24, 2021 (GLOBE NEWSWIRE) — Mainframe Studios, a division of WOW! Unlimited Media Inc. (“WOW!” or the “Company”) (TSXV: WOW; OTCQX: WOWMF), expands the diversity of their content with a dedicated 2D Pipeline. The award-winning CG animation studio is elevating their creative roster with a newly appointed team of 2D animation storytellers. Already a leader in the 3D animation space, Mainframe’s constant drive to innovate has resulted in shows that incorporate live action and Epic’s real-time Unreal engine. Branching into 2D production furthers the studio’s range of creative approach for both original IP and service projects. Mainframe’s original IP The Guava Juice Show, a YouTube Originals, is the studio’s first 2D animation series out of the gate...

Continue reading

Purpose Investments Inc. Announces 2021 Second Quarter Distributions for Purpose Specialty Lending Trust

Purpose Investments Inc. Announces 2021 Second Quarter Distributions for Purpose Specialty Lending Trust

TORONTO, June 24, 2021 (GLOBE NEWSWIRE) — Purpose Investments Inc. is pleased to announce the 2021 second quarter distributions for Purpose Specialty Lending Trust.   Ticker Symbol Distributionper share/unit Ex Distribution Date Record Date Payable Date Purpose Specialty Lending Trust – Class A Unlisted $0.1160 06/29/2021 06/30/2021 07/23/2021 Purpose Specialty Lending Trust – Class F Unlisted $0.1200 06/29/2021 06/30/2021 07/23/2021 Purpose Specialty Lending Trust – Class U Unlisted US$ 0.1425 06/29/2021 06/30/2021 07/23/2021 Purpose Specialty Lending Trust – Class A1, Series 2 Unlisted $0.1350 06/29/2021 06/30/2021 07/23/2021 Purpose Specialty Lending Trust – Class F, Series 3 Unlisted $0.1400 06/29/2021 06/30/2021 07/23/2021 About Purpose Investments Inc. Purpose Investments Inc. is an asset management company...

Continue reading

Bioventus Invests in Vaporox

Bioventus Invests in Vaporox

Ultrasonic Technology to Heal Diabetic Foot Ulcers DURHAM, N.C., June 24, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a minority investment in Vaporox, Inc., a developer of a highly innovative diabetic foot ulcer (“DFU”) wound healing therapy. Founded in 2016, Vaporox is based in Denver, Colorado and has developed a patented, ultrasonic technology, Vaporous Hyperoxia Therapy™ (“VHT”), that has demonstrated the ability to heal approximately 85% of DFUs that were unresponsive to the current standard of care. DFUs represent a tremendous cost to the health care system and are one of the most common and severe complications associated with diabetes. Foot and ankle surgeons are the leading specialty treating the over two million...

Continue reading

CTO Realty Growth Announces the Acquisition of the Shops at Legacy in the Plano Submarket of Dallas, Texas for $72.5 Million

CTO Realty Growth Announces the Acquisition of the Shops at Legacy in the Plano Submarket of Dallas, Texas for $72.5 Million

DAYTONA BEACH, Fla., June 24, 2021 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced it has acquired The Shops at Legacy North, an approximately 236,000 square foot retail-driven mixed-use lifestyle property in Plano, Texas (the “Property”). The Shops at Legacy North, which was constructed in 2007 and includes nearly 1,000 parking spaces, is currently 83% occupied and is situated on 12.7 acres across the Dallas North Tollway from Legacy West at the core of the 2,665-acre master-planned Legacy District, one of the premier live-work-play communities in the United States. The Property has excellent accessibility to a large concentration of Fortune 500 Companies, is surrounded by approximately 8,000 apartment units and nearly 2,500 hotel rooms, and benefits from excellent demographics with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.